Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Zlin – page 5

76 clinical trials in Zlin, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Zlin at a glance
76
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

76 trials in Zlin

Open in trial search
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Atrial fibrillation

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International

Arteriosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Ublituximab
  • Sponsor:Tg Therapeutics Inc.

Rheumatoid arthritis

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Multiple sclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Jnj-77242113
  • Sponsor:Janssen - Cilag International

Multiple sclerosis

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Psoriatic arthropathy

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Zlin

What the registry says about research in the country

01 Rheumatology Studies

Extensive research focusing on psoriatic arthritis treatments, including multiple trials evaluating novel therapies like zasocitinib, sonelokimab, and bimekizumab for patients with varying treatment histories. Additional studies explore treatments for polymyalgia rheumatica and rheumatoid arthritis.

  • Psoriatic Arthritis Treatments
  • Inflammatory Joint Conditions
  • Autoimmune Disorders
02 Cardiovascular Research

Innovative trials addressing atherosclerotic cardiovascular disease and stroke prevention. Studies evaluate new treatments like pelacarsen for lipoprotein management and asundexian for stroke prevention in patients with atrial fibrillation.

  • Heart Disease Prevention
  • Stroke Management
  • Vascular Disorders
03 Neurological Studies

Research initiatives examining treatments for multiple sclerosis, including studies of frexalimab and tolebrutinib. Additional focus on neurosurgical interventions and their postoperative outcomes.

  • Multiple Sclerosis Therapies
  • Neurosurgical Outcomes
  • Neurological Disorders
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.